Skip to content

The Minimum Effective Volume of 0.5% Ropivacaine for Ultrasound-Guided Erector Spinae Plane Block Analgesia After Thoracoscopic Surgery

The Minimum Effective Volume of 0.5% Ropivacaine for Ultrasound-Guided Erector Spinae Plane Block Analgesia After Thoracoscopic Surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084646
Enrollment
Unknown
Registered
2024-05-22
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Test group:Adjust the volume of 0.5 % ropivacaine one by one.

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1: candidates scheduled for thoracoscopic lobectomy at our institution; 2: individuals aged 18-75 years, with a height of 150-180 cm and a BMI of 18-35 kg/m^2; 3: patients classified as American Society of Anesthesiologists (ASA) grade I-III.

Exclusion criteria

Exclusion criteria: 1: refusal to provide informed consent; 2: inability to comply with the research protocol; 3: pregnancy, as indicated by a positive maternal or urinary pregnancy test; 4: preoperative use of analgesics or medications affecting neurological function; 5: history of opioid usage; 6: spinal deformity, abnormal coagulation function, or infection at the puncture site; 7: mental illness or other factors preventing cooperation; 8: allergy to local anesthetics or drugs used during surgery; 9: inability to understand or use the Visual Analogue Scale (VAS) for pain or Patient-controlled Intravenous Analgesia (PCIA).

Design outcomes

Primary

MeasureTime frame
The erector spinae plane block was successful;

Secondary

MeasureTime frame
Total postoperative use of opioid drugs;safety;

Countries

China

Contacts

Public ContactChunmei Wang

The First Affiliated Hospital of Dalian Medical University

fangzhaoyi2000@163.com+86 187 4254 8105

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026